GlassScriptPhysician profile
Emilio Oribe
NPI 1689624785
$560.71
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $69.87 · 2021: $101.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $213.66 | 2019 | |
| Siemens Medical Solutions USA, INC. | $94.68 | 2019 | |
| Abbvie INC. | $61.22 | 2021 | |
| Allergan, INC. | $43.81 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $41.86 | 2020-2021 | |
| Amgen INC. | $33.62 | 2019 | |
| Viiv Healthcare Company | $23.32 | 2019 | |
| Upsher-Smith Laboratories LLC | $18.89 | 2021 | |
| Lundbeck LLC | $16.06 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilio Oribe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.